Literature DB >> 8269950

Alanine scanning mutagenesis of human erythropoietin identifies four amino acids which are critical for biological activity.

J Grodberg1, K L Davis, A J Sykowski.   

Abstract

Erythropoietin regulates the growth and proliferation of red blood cell progenitors. We demonstrated previously the important structural and functional roles of the amino acid region 99-110 in the biological activity of the hormone. [Chern, Y., Chung, T. & Sytkowski, A. J. (1991) Eur. J. Biochem. 202, 225-229]. We have now performed alanine scanning mutagenesis to identify which specific residues in this region are essential for function. Four substitutions reduced the biological activity of erythropoietin. Alanine substitution of Ser104, Leu105 and Leu108 reduced activity to 16, 44, and 37% that of the wild-type protein, respectively. Most significantly, substitution of Arg103 with Ala reduced activity to undetectable levels, indicating a > 230-fold reduction in specific activity. Immunochemical analyses using anti-peptide monoclonal antibodies demonstrated that this substitution does not cause major changes in the conformation of the protein or large, localized distortions within the amino acid region 99-129 of the molecule. Heat-denaturation kinetics for the arginine mutant and wild-type erythropoietin are virtually identical, further indicating the structural similarity between these two molecules. Based upon these findings, we propose that Arg103 plays an essential role in the biological activity of erythropoietin, presumably by interacting directly with the erythropoietin receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269950     DOI: 10.1111/j.1432-1033.1993.tb18413.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Effects of localized interactions and surface properties on stability of protein-based therapeutics.

Authors:  Brittney J Mills; Jennifer S Laurence Chadwick
Journal:  J Pharm Pharmacol       Date:  2016-11-10       Impact factor: 3.765

2.  Functional and structural analysis of the sialic acid-binding domain of rotaviruses.

Authors:  P Isa; S López; L Segovia; C F Arias
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Variability in the immunodetection of His-tagged recombinant proteins.

Authors:  Natasa Debeljak; Laurie Feldman; Kerry L Davis; Radovan Komel; Arthur J Sytkowski
Journal:  Anal Biochem       Date:  2006-11-01       Impact factor: 3.365

4.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Authors:  Michael D Feese; Taro Tamada; Yoichi Kato; Yoshitake Maeda; Masako Hirose; Yasuko Matsukura; Hideki Shigematsu; Takanori Muto; Atsushi Matsumoto; Hiroshi Watarai; Kinya Ogami; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

5.  A sequential dimerization mechanism for erythropoietin receptor activation.

Authors:  D J Matthews; R S Topping; R T Cass; L B Giebel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

6.  The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin.

Authors:  Kazumichi Nagasawa; Mizue Meguro; Kei Sato; Yuta Tanizaki; Nami Nogawa-Kosaka; Takashi Kato
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 7.  Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care.

Authors:  Nimesh S A Patel; Kiran K Nandra; Christoph Thiemermann
Journal:  Crit Care       Date:  2012-07-26       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.